Biobase and Techcyte partner to advance digital pathology and unlock the full potential of clinical data

Techcyte, developer of the Fusion unified digital pathology platform, and Biobase, creator of an agentic data discovery platform for connecting multi-modal clinical data to pharma and research buyers, announced a strategic partnership designed to allow laboratories to commercialize their de-identified data to help offset the costs of going digital.

By connecting the Techcyte Fusion^® platform to the Biobase federated data discovery platform, pharma and research organizations  can use agentic search to discover, manage, and provide access to both digital and physical samples.

Laboratories retain full control and can selectively participate in research and commercial collaborations with minimal effort. Labs may opt in at a general level or decide  whether or not to engage in each individual data collaboration.

Techcyte’s Fusion platform streamlines pathology workflows by integrating AI-assisted image analysis, workflow orchestration, and LIS interoperability. With the addition of Biobase’s capabilities, Fusion now provides a path to expand the value of their clinical data.

“Techcyte Fusion integrates AI deeply into pathology workflows to improve efficiency,” said Ben Cahoon, CEO of Techcyte. “Partnering with Biobase adds a powerful new dimension, allowing our customers to tap into the scientific and economic value of their data.”

“We built Biobase to help labs unlock the latent potential of their data,” said Todd Parker, CEO and Co-Founder of Biobase. “With Techcyte, we’re combining state-of-the-art digital pathology workflows with AI-driven data discovery, so laboratories can move effortlessly from case review to data monetisation, all while maintaining complete control and compliance.”

###

About Biobase

Biobase is an AI-driven platform for the secure, compliant commercialization of healthcare datasets, including pathology images, molecular and genomic data, and associated clinical information. Using agentic AI, natural language semantic search, and multimodal data integration, Biobase connects data owners with qualified buyers in research, pharma, and diagnostics—turning dormant data into new revenue streams and accelerating medical innovation. Learn more at www.biobase.ai.